Hoping to bag the boosted CSL dividend? Time is running out

Here's how you can secure the largest ever CSL dividend.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last month, we covered the latest earnings from ASX 200 healthcare share CSL Limited (ASX: CSL). As we reported at the time, CSL's earnings report covering the 2023 financial year was well received by investors. And no doubt the latest CSL dividend was a factor there. 

Last month, CSL revealed that it had brought in a 13% increase in revenues for FY23 to US$13.31 billion. Net profit after tax before amortisation rose by 20% in constant currency to US$2.86 billion, while reported net profits were up 10% to US$2.61 billion.

This all enabled CSL to reveal a final dividend of US$1.29 per share, partially franked at 10%. That's the largest dividend (in US dollar terms) that CSL has ever paid out and a big rise over last year's corresponding payment of US$1.18 per share. It takes the company's full-year dividend payments to a total of US$2.36 per share. That's a 6% rise over FY22's levels.

We don't yet know exactly how much this division will be worth yet in Australian dollar terms. 13 September has been set aside for that determination. But at the current exchange rates, this would equate to a payment worth approximately $2.02 per share.

So this was clearly exciting news for investors. On the day the results were released, the CSL share price climbed a healthy 3.73%. Today, the company's shares remain more than 2% above where they were before the earnings came out, as you can see below:

However, while this new CSL dividend might be an exciting one for investors to contemplate, time is running out if they want to secure it. That's because the ex-dividend date for this payment is fast approaching.

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.

Image source: Getty Images

How to bag the next CSL dividend

Whenever an ASX share announces a dividend payment, it also must pick a date preceding the payment day that determines the eligibility of shareholders to receive it. Put simply, if you own CSL shares before the ex-dividend date, you will get the dividend. But if you buy CSL shares on or after the ex-dividend date, you miss out.

As such, we tend to see a large share price drop whenever a share trades ex-dividend, reflecting this loss of value for new investors.

So for CSL's upcoming final dividend, the ex-dividend date has been set for 11 September. That's next Monday. This means that if you want to see the latest CSL dividend arrive in your bank account, you will need to be quick and own CSL shares as of close of trading tomorrow.

Payment day for this dividend will then come on 4 October next month.

Right now, CSL shares offer a dividend yield of 1.14%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Female scientist working in a laboratory.
Healthcare Shares

Down almost 20% this year, how high could Mesoblast shares go?

The forward pipeline is looking promising.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?

These three stocks might be too cheap to ignore.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

How much would $10,000 become if CSL shares returned to their record high?

After a sharp decline, CSL is in a new phase. The question is what happens next.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Healthcare Shares

Why this ASX biotech stock just rocketed 89% today

Immutep shares rocket after a fresh FDA win

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX biotech stock just jumped again as its lead drug trial moves ahead

The latest trial milestone sends this ASX biotech stock higher today.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why are Telix shares sinking 7.5% today?

Let's see what this healthcare stock has announced today.

Read more »

A smiling businessman sits at a desk with bags of mony, indicating a share price rise after funding has been approved
Healthcare Shares

Telix Pharmaceuticals upsizes convertible bonds to US$600 million

Telix Pharmaceuticals has upsized its convertible bond issue to US$600 million, enhancing financial flexibility and repurchasing existing bonds.

Read more »